Skip to main content
Journal cover image

OPTN/SRTR 2024 Annual Data Report: Vascularized Composite Allograft.

Journal articles  - Journal Article
Nichols, DS; Testa, G; Johannesson, L; Miller, JM; Schnellinger, EM; Studenic, E; Hart, A; Snyder, JJ; Cendales, LC
Published in: Am J Transplant
June 2026

This chapter provides a comprehensive summary of data collected over roughly the past decade, beginning in 2014 when vascularized composite allografts (VCAs) were incorporated into the Final Rule and brought under the definition of solid organ transplantation. As in previous years, the number of VCA procedures in the United States remains low, with 55 uterus transplants and 37 nonuterus transplants reported from 2014 through 2024. While the limited volume precludes definitive conclusions, several consistent trends are observed. Among nonuterus VCA transplants, upper limb remained the most common overall, although head and neck transplants were most frequent in 2024. Nonuterus transplants in 2014-2024 were most often performed in recipients aged 18-34 years, with donors typically drawn from the same age range. Trauma remained the leading indication for nonuterus VCA transplant. White and male recipients were the most common recipients of nonuterus VCA transplant. Uterus transplants were most frequently performed in White women aged 18-34 years, typically for congenital indications. From 2016 through 2024, there were 10 reported uterus graft failures, and only one reported failure of a nonuterus graft-in the upper limb category-since 2014. Although the number of transplants and reported graft failures remained relatively low, the field continues to advance through ongoing efforts to develop standardized outcome measures, standardized definitions of graft success and failure, and standard operating procedures in hand and face transplantation. These initiatives are beneficial for improving data comparability, guiding clinical decision-making, and supporting sustained progress in VCA research and patient care.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am J Transplant

DOI

EISSN

1600-6143

Publication Date

June 2026

Volume

26

Issue

8S1

Start / End Page

S585 / S612

Location

United States

Related Subject Headings

  • Vascularized Composite Allotransplantation
  • United States
  • Tissue and Organ Procurement
  • Tissue Donors
  • Surgery
  • Male
  • Humans
  • Graft Survival
  • Female
  • Composite Tissue Allografts
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Nichols, D. S., Testa, G., Johannesson, L., Miller, J. M., Schnellinger, E. M., Studenic, E., … Cendales, L. C. (2026). OPTN/SRTR 2024 Annual Data Report: Vascularized Composite Allograft. Am J Transplant, 26(8S1), S585–S612. https://doi.org/10.1016/j.ajt.2026.05.726
Nichols, D Spencer, Giuliano Testa, Liza Johannesson, Jonathan M. Miller, Erin M. Schnellinger, Ethan Studenic, Allyson Hart, Jon J. Snyder, and Linda C. Cendales. “OPTN/SRTR 2024 Annual Data Report: Vascularized Composite Allograft.Am J Transplant 26, no. 8S1 (June 2026): S585–612. https://doi.org/10.1016/j.ajt.2026.05.726.
Nichols DS, Testa G, Johannesson L, Miller JM, Schnellinger EM, Studenic E, et al. OPTN/SRTR 2024 Annual Data Report: Vascularized Composite Allograft. Am J Transplant. 2026 Jun;26(8S1):S585–612.
Nichols, D. Spencer, et al. “OPTN/SRTR 2024 Annual Data Report: Vascularized Composite Allograft.Am J Transplant, vol. 26, no. 8S1, June 2026, pp. S585–612. Pubmed, doi:10.1016/j.ajt.2026.05.726.
Nichols DS, Testa G, Johannesson L, Miller JM, Schnellinger EM, Studenic E, Hart A, Snyder JJ, Cendales LC. OPTN/SRTR 2024 Annual Data Report: Vascularized Composite Allograft. Am J Transplant. 2026 Jun;26(8S1):S585–S612.
Journal cover image

Published In

Am J Transplant

DOI

EISSN

1600-6143

Publication Date

June 2026

Volume

26

Issue

8S1

Start / End Page

S585 / S612

Location

United States

Related Subject Headings

  • Vascularized Composite Allotransplantation
  • United States
  • Tissue and Organ Procurement
  • Tissue Donors
  • Surgery
  • Male
  • Humans
  • Graft Survival
  • Female
  • Composite Tissue Allografts